Get startedLog in
    Picture of Kaken Pharmaceutical Co logo

    4521 — Kaken Pharmaceutical Co Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Kaken Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoTanshin
    Standards:———
    JAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line13,8856,8179,79619,4352,313
    Depreciation
    Amortisation
    Non-Cash Items2,5151,515-2871,290-3,155
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-5,549-1,647-9,6856,500-13,562
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities13,3379,2532,57729,779-11,079
    Capital Expenditures-3,257-2,206-2,167-4,392-5,423
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-4,631-421-3,687-15,2585,738
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-7,888-2,627-5,854-19,650315
    Financing Cash Flow Items-1-1-1——
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Cash from Financing Activities-8,129-6,990-5,658-13,133-8,841
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-2,680-364-8,9354,760-19,380